ID   SK-OV-3-Cas9-564
AC   CVCL_XB86
DR   cancercelllines; CVCL_XB86
DR   CCRID; 1101HUM-PUMC000564
DR   Wikidata; Q98132668
CC   Population: Caucasian.
CC   Characteristics: Transfected with a Cas9-Flag-Neo construct.
CC   Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Transfected with: UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 22
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 16,17,18
ST   D19S433: 14,14.2
ST   D21S11: 30,31.2
ST   D2S1338: 18,23
ST   D3S1358: 14
ST   D5S818: 10,11
ST   D6S1043: 12
ST   D7S820: 13,14
ST   D8S1179: 14,15
ST   FGA: 24,25
ST   Penta E: 5,13
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 9
//